Published in Clin Liver Dis on July 31, 2013
Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis. Dig Dis Sci (2014) 1.27
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol (2015) 0.92
Evaluation of Possible Genotoxic Activity of Dirithromycin in Cultured Human Lymphocytes. J Toxicol (2015) 0.75
Drug-induced liver injury: Do we know everything? World J Hepatol (2017) 0.75
Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time? Dig Dis Sci (2007) 1.83
Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis (2007) 1.32
Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis. Dig Dis Sci (2014) 1.27
High-resolution chromoendoscopy for classifying colonic polyps: a multicenter study. Gastrointest Endosc (2002) 1.14
The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc (2004) 1.11
Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation. Chemotherapy (2008) 1.07
Hepatic findings in long-term clinical trials of ximelagatran. Drug Saf (2005) 1.05
Drug-induced liver injury: a summary of recent advances. Expert Opin Drug Metab Toxicol (2011) 1.05
Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis (2010) 1.00
Pancreatic tuberculosis diagnosed with endoscopic ultrasound guided fine needle aspiration. JOP (2005) 0.99
Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy. Arthritis Care Res (Hoboken) (2010) 0.99
Drug-induced liver injury in 2007. Curr Opin Gastroenterol (2008) 0.96
Drug- and chemical-induced cholestasis. Clin Liver Dis (2004) 0.93
Drug-induced liver injury: what was new in 2008? Expert Opin Drug Metab Toxicol (2009) 0.92
Predicting and preventing acute drug-induced liver injury: what's new in 2010? Expert Opin Drug Metab Toxicol (2010) 0.91
Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring. J Natl Med Assoc (2010) 0.90
Drug-induced liver disease in 2006. Curr Opin Gastroenterol (2007) 0.87
Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic. J Natl Med Assoc (2005) 0.87
Drug-induced liver disease 2004. Curr Opin Gastroenterol (2005) 0.84
Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERS. Drug Saf (2014) 0.81
Latest advances in predicting DILI in human subjects: focus on biomarkers. Expert Opin Drug Metab Toxicol (2012) 0.81
Dermatologists' awareness of and screening practices for hepatitis B virus infection before initiating tumor necrosis factor-α inhibitor therapy. South Med J (2011) 0.80
Drug-induced liver disease in 2003. Curr Opin Gastroenterol (2004) 0.80
Drug-induced liver injury in the elderly. Curr Gastroenterol Rep (2013) 0.79
Drug-induced liver injury: what was new in 2013? Expert Opin Drug Metab Toxicol (2014) 0.78
Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials. Drug Saf (2014) 0.78
Fatal varicella-zoster hepatitis presenting with severe abdominal pain: a case report and review of the literature. Dig Dis Sci (2006) 0.77
Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitis. Nat Rev Gastroenterol Hepatol (2011) 0.76
Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection. Ann Pharmacother (2007) 0.76
Drug-induced liver disease. Curr Opin Gastroenterol (2003) 0.75
Relationship between certain medications and cirrhosis. Am Fam Physician (2007) 0.75
Did this drug cause my patient's hepatitis? Ann Intern Med (2003) 0.75
How the FDA handles GI drug safety. Am J Gastroenterol (2012) 0.75
The safety of same-day endoscopy and percutaneous liver biopsy. Dig Dis Sci (2010) 0.75
Use of endoclips to obliterate a colonic arteriovenous malformation before cauterization. Gastrointest Endosc (2006) 0.75
Polypharmacy and comorbidity are associated with a lower early virologic response in hepatitis C patients treated with first generation protease inhibitor triple therapy: a preliminary analysis. Dig Dis Sci (2013) 0.75